As of 2025-11-13, the Intrinsic Value of OKYO Pharma Ltd (OKYO.L) is -58.96 GBP. This OKYO.L valuation is based on the model Peter Lynch Fair Value. With the current market price of 91.00 GBP, the upside of OKYO Pharma Ltd is -164.79%.
Based on its market price of 91.00 GBP and our intrinsic valuation, OKYO Pharma Ltd (OKYO.L) is overvalued by 164.79%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -58.96 - -58.96 | -58.96 | -164.79% |
| P/E | (165.08) - (478.74) | (367.60) | -504.0% |
| DDM - Stable | (55.87) - (142.25) | (99.06) | -208.9% |
| DDM - Multi | (0.81) - (1.58) | (1.06) | -101.2% |
| Market Cap (mil) | 30.69 |
| Beta | 0.71 |
| Outstanding shares (mil) | 0.34 |
| Enterprise Value (mil) | 30.05 |
| Market risk premium | 6.41% |
| Cost of Equity | 15.12% |
| Cost of Debt | 5.00% |
| WACC | 9.93% |